Sarah Kalil Net Worth & Insider Trades

Sarah Kalil - Chief Operating Officer, T2 Biosystems, Inc

As of January 26, 2016

What is Sarah Kalil's Net Worth?

The current estimated net worth of T2 Biosystems, Inc's Chief Operating Officer, Sarah Kalil, is estimated to be about $27.9K . Sarah Kalil owns about 61,500 units of T2 Biosystems, Inc common stock. In the last year at T2 Biosystems, Inc, Sarah Kalil has sold an estimated value of $0 worth.

What is Sarah Kalil's Past Insider Trading?

Sarah Kalil's largest purchase order was 5,000 units , worth over $55K on April 30, 2015. In total, Sarah Kalil has made about 4 transactions over a year of their time at T2 Biosystems, Inc. Sarah Kalil usually trades in March, with the busiest year in 2015.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Sarah Kalil's' Mailing Address?

  • Mailing address is T2 Biosystems, Inc. 101 Hartwell Ave Lexington MA 02421 MA

T2 Biosystems, Inc Executive Compensation

Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
John Sperzel, 2020 $490,705 - - $2,571,384 $393,750 $3,000 $3,458,839
John McDonough, 2020 $72,906 - $74,999 - - $1,022,182 $1,170,087
John McDonough, 2019 $550,000 - $372,000 $478,728 $233,750 $3,000 $1,637,478
Alec Barclay, 2020 $340,000 - $25,675 $38,621 $234,600 $952 $639,848
Alec Barclay, 2019 $337,500 $35,000 $111,600 $348,834 $102,000 $2,900 $937,834
Anthony Pare, 2020 $325,000 - $20,738 $159,763 $185,250 $3,000 $693,751
No matching records found


What are T2 Biosystems, Inc's Past Insider Trades?

T2 Biosystems, Inc's most recent insider trade came on September 29, 2023 by CR Group Lp, Crg Partners Iii Lp, Crg Partners Iii Parallel Fund A Lp, Crg Partners Iii Cayman Unlev Aiv I Lp and Crg Partners Iii Cayman Lev Aiv I Lp who sold 13,130,147 units worth $2.27M . In the last 9 years, insiders at T2 Biosystems, Inc have sold an estimated value of $21.95M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer,  David Elsbree,  and Terrence Michael Gibbs, General Counsel .

T2 Biosystems, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found